Chen Zhihao, Wu Jianhong, Sun Kening, He Yijun, Zhu Zhenfang, Xiao Li, Sheng Lu
Department of Urology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Department of Image, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Prostate. 2022 Apr;82(5):566-575. doi: 10.1002/pros.24303. Epub 2022 Jan 24.
To determine the prostate cancer biochemical recurrence-related fusion biopsy characteristics before radical surgery and to establish the risk prediction model of biochemical recurrence of prostate cancer.
Three hundred and four patients undergoing radical surgery for prostate cancer at Huadong Hospital affiliated to Fudan University between 2009 and 2020 for preoperative magnetic resonance imaging (MRI) before biopsy with suspicious prostate cancer lesions. Each case was followed by a 10 + x needle combination of targeted biopsy (intentional or robotic fusion) with systematic biopsy. Prostate-specific antigen levels were measured at 1, 3, and 6 months postoperatively, followed by reexamination every 6 months. Survival analysis was performed by the Kaplan-Meier method, univariate and multivariate analysis by Cox, and Logistic risk regression models.
Higher Prostate Imaging Reporting And Data System (PI-RADS) scores (p < 0.001), suspicious extracapsular invasion (p < 0.001), and seminal vesicle invasion (p < 0.001) on MRI, the largest lesion diameter on MRI (p = 0.006), higher biopsy International Society of Urological Pathology (ISUP) grade group (p < 0.001) related to higher biochemical recurrence rates, higher pathological staging (p < 0.001), and a greater probability of local lymph node metastasis (p < 0.001). We accurately predicted the biochemical recurrence of prostate cancer after radical surgery based on preoperative features including the long diameter of the largest MRI lesion more than 23 mm, seminal vesicle invasion on MRI, and targeted fusion biopsy ISUP grade >3 Risk stratified classification (AUC = 0.729, p < 0.001). In our cohort, this risk stratification had a larger area under the curve than predictive models based only on magnetic resonance parameters and traditional risk scores.
In this cohort, seminal vesicle invasion on MRI, the long diameter of the largest MRI lesion, and targeted fusion biopsy ISUP grade grope are significantly predictive of pathologic features and biochemical recurrence after prostate surgery. The risk stratification integrating the three parameters could better predict the biochemical recurrence than the traditional model.
确定前列腺癌根治术前与生化复发相关的融合活检特征,并建立前列腺癌生化复发的风险预测模型。
2009年至2020年期间,304例在复旦大学附属华东医院接受前列腺癌根治术的患者,术前进行磁共振成像(MRI)检查,活检前有可疑前列腺癌病变。每例患者均采用10+x针组合的靶向活检(经会阴或机器人融合)与系统活检。术后1、3和6个月测量前列腺特异性抗原水平,随后每6个月复查一次。采用Kaplan-Meier法进行生存分析,Cox法进行单因素和多因素分析,以及Logistic风险回归模型。
MRI上较高的前列腺影像报告和数据系统(PI-RADS)评分(p<0.001)、可疑的包膜外侵犯(p<0.001)和精囊侵犯(p<0.001)、MRI上最大病变直径(p=0.006)、较高的活检国际泌尿病理学会(ISUP)分级组(p<0. <0.001)与较高的生化复发率、较高的病理分期(p<0.001)以及局部淋巴结转移的可能性较大(p<0.001)相关。我们基于术前特征准确预测了前列腺癌根治术后的生化复发,这些特征包括MRI上最大病变的长径超过23mm、MRI上的精囊侵犯以及靶向融合活检ISUP分级>3的风险分层分类(AUC=0.729,p<0.001)。在我们的队列中,这种风险分层的曲线下面积比仅基于磁共振参数和传统风险评分的预测模型更大。
在这个队列中,MRI上的精囊侵犯、MRI上最大病变的长径以及靶向融合活检ISUP分级组对前列腺手术后的病理特征和生化复发具有显著的预测作用。整合这三个参数的风险分层比传统模型能更好地预测生化复发。